Work

Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint

Year: 2010

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/j.jcf.2010.05.004

Authors: M.W. Konstan, J.S. Wagener, A. Yegin, S.J. Millar, D.J. Pasta, D.R. VanDevanter

Institutions: Case Western Reserve University, University of Colorado Anschutz, University of Colorado Denver, Genentech

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cystic Fibrosis Foundation, National Institute of Diabetes and Digestive and Kidney Diseases

Award: Translational Research in Cystic Fibrosis

OpenAlex ID: W2069648171

FWCI: 4.001

Cites: 16

Cited by: 43

Related to: 10